Optogenetic induction of the schizophrenia-related endophenotype of ventral hippocampal hyperactivity causes rodent correlates of positive and cognitive symptoms.

Scientific Reports
Amy R WolffDennis Kätzel

Abstract

Pathological over-activity of the CA1 subfield of the human anterior hippocampus has been identified as a potential predictive marker for transition from a prodromal state to overt schizophrenia. Psychosis, in turn, is associated with elevated activity in the anterior subiculum, the hippocampal output stage directly activated by CA1. Over-activity in these subfields may represent a useful endophenotype to guide translationally predictive preclinical models. To recreate this endophenotype and study its causal relation to deficits in the positive and cognitive symptom domains, we optogenetically activated excitatory neurons of the ventral hippocampus (vHPC; analogous to the human anterior hippocampus), targeting the ventral subiculum. Consistent with previous studies, we found that vHPC over-activity evokes hyperlocomotion, a rodent correlate of positive symptoms. vHPC activation also impaired performance on the spatial novelty preference (SNP) test of short-term memory, regardless of whether stimulation was applied during the encoding or retrieval stage of the task. Increasing dopamine transmission with amphetamine produced hyperlocomotion, but was not associated with SNP impairments. This suggests that short-term memory impairm...Continue Reading

References

Jul 8, 1999·Biological Psychiatry·D MalaspinaR Van Heertum
Dec 6, 2001·Hippocampus·D R MedoffC A Tamminga
Mar 19, 2003·Behavioural Brain Research·D M BannermanJ N P Rawlins
Jul 1, 2004·Neuroscience and Biobehavioral Reviews·D M BannermanJ Feldon
Jun 27, 2007·Behavioral Neuroscience·D J SandersonD M Bannerman
Oct 19, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Daniel J Lodge, Anthony A Grace
Aug 1, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Daniel J Lodge, Anthony A Grace
Jan 17, 2009·The American Journal of Psychiatry·Jason R TregellasDonald C Rojas
Jul 21, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Marion JalabertFrançois Georges
Jul 21, 2010·Clinical Schizophrenia & Related Psychoses·Christina Wilson, Alvin V Terry
Sep 3, 2010·The American Journal of Psychiatry·Carol A TammingaAnthony D Wagner
Nov 12, 2010·Nature·Thomas R Insel
Feb 12, 2011·Current Topics in Behavioral Neurosciences·Stephan Heckers, Christine Konradi
Aug 13, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Louisa LyonDavid M Bannerman
Mar 20, 2013·Frontiers in Integrative Neuroscience·Valentina Wiescholleck, Denise Manahan-Vaughan
Mar 26, 2013·Neuron·Sebastien ParnaudeauChristoph Kellendonk
Aug 27, 2013·Neuron·Ada C Felix-OrtizKay M Tye
Oct 8, 2013·Biological Psychiatry·Jason R Tregellas
Jan 18, 2014·The American Journal of Psychiatry·Jason R TregellasRobert Freedman
Feb 11, 2014·Nature Methods·Nathan C KlapoetkeEdward S Boyden
Aug 28, 2014·NeuroImage. Clinical·Pratik TalatiStephan Heckers
Nov 8, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Robin NguyenJun Chul Kim

❮ Previous
Next ❯

Citations

Nov 13, 2020·Frontiers in Pharmacology·Dennis KätzelDavid M Bannerman
Jun 24, 2021·Behavioral and Brain Functions : BBF·Enrico PatronoAleš Stuchlík
Oct 1, 2021·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Samuel J MillardMelissa J Sharpe

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
transfection

Software Mentioned

AnyMaze

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.